Counts of positive / neutral / negative news items — not a price chart.
Informational only — not investment advice. Sentiment reflects news exposure, not a buy/sell recommendation or price forecast. Do your own research and consult a licensed professional.
The items moving the net sentiment the most, by direction and influence.
Pakistan Pharma Association Warns on Drug Price Deregulation Reversal: Pharma Stocks Face Headwinds
Drug pricing (DRAP) · High influence · Long term
Drug Pricing Deadlock Causes Shortages: Pharmaceutical Stocks Face Headwinds
Drug pricing (DRAP) · High influence · Long term
Budget Removes Tax on Sanitary Products, Contraceptives: Consumer and Pharma Stocks May Benefit
Direct news · Medium influence · Long term
Pakistan Cuts Pharma Tariffs to Boost Drug Production: Positive for Local Drug Makers
Budget taxation (GST/FED/duties) · Medium influence · Long term
Drug Deregulation Reversal Threatens Pharma Stocks: PPMA Warns of Shortages
Drug pricing (DRAP) · Medium influence · Long term
Macro, commodity, FX and regulatory forces that moved ABOT in this range, with the stories behind each.
Sign up free to track ABOT, unlock full history and the complete driver breakdown, and get alerts when sentiment shifts.
Track ABOT — freeInformational only — not investment advice. Sentiment reflects news exposure, not a buy/sell recommendation or price forecast. Do your own research and consult a licensed professional.
Pakistan Pharma Profits Hit Record Rs42 Billion in 2025 on Deregulation: Searle, Abbott, AGP, Highnoon
